Drug-eluting stents: a comprehensive appraisal. - Wikidata - wikimedia - TriplyDB

Drug-eluting stents: a comprehensive appraisal.

Drug-eluting stents: a comprehensive appraisal.

http://www.wikidata.org/entity/Q37445860

about

Reduced mortality and moderate alcohol consumption: the phospholipase D-mTOR connection A patient with repeated catastrophic multi-vessel coronary spasm after zotarolimus-eluting stent implantation.Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.Site-specific gene therapy for cardiovascular disease.Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.Risk evaluation and mitigation strategies: a focus on the mammalian target of rapamycin inhibitors.Plasma torch toothbrush a new insight in fear free dentisry.Enhanced biocompatibility of CD47-functionalized vascular stents.Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.Comparison of neointimal morphology of in-stent restenosis with sirolimus-eluting stents versus bare metal stents: virtual histology-intravascular ultrasound analysis.

P2860

Q34213257-A383DB3D-3266-4165-8664-F155747F1A38 Q36601920-D03A7111-61B3-4327-AA29-4A4D86168026 Q37685137-C953FE7B-D496-4181-9DB4-1B162EB10511 Q37703070-EB25B228-5192-456D-988D-661C4B4F29BC Q37793095-4CE875BD-520C-4787-9CF6-65843875D55D Q38085437-0830D7BF-689F-4B0D-A0FE-2A7D4B15DDB3 Q38239697-0D579982-3F5C-4343-A0F5-84F0B8842703 Q38791109-8E4724ED-44CF-4B08-86A7-2F4B6C73F95B Q42577905-D0F7CB9B-E641-4E7D-BBD8-97EADB2C9D7E Q44047046-3F60E92D-FAC2-4CFB-9872-5E2BE59A0C55

P2860

Drug-eluting stents: a comprehensive appraisal.

http://www.wikidata.org/entity/Q37445860

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug-eluting stents: a comprehensive appraisal.

@en

Drug-eluting stents: a comprehensive appraisal.

@nl

type

label

Drug-eluting stents: a comprehensive appraisal.

@en

Drug-eluting stents: a comprehensive appraisal.

@nl

prefLabel

Drug-eluting stents: a comprehensive appraisal.

@en

Drug-eluting stents: a comprehensive appraisal.

@nl

P1433

Q37445860-0DE1AA1A-4F87-4889-A6BD-C362BE4C1837

P1476

Q37445860-E8186B14-1A97-4D61-8FD8-06497ED8C6FC

P2093

Q37445860-7CE4A7EA-AFDE-4ADE-A18B-06E253709446

Q37445860-FF30FB24-F727-48B1-9C94-ADAA84BD34D3

P2860

Q37445860-02EB6DBB-AF10-43E2-8068-E04012B00B39

Q37445860-0314248D-3344-400C-97C0-DD723624E6E8

Q37445860-033116FF-82E8-4CD3-A9FF-70DBAB038346

Q37445860-05D63330-DDD1-4C78-BF04-A10A4038CBB1

Q37445860-0735E581-7282-46CB-831B-0166B7568202

Q37445860-09F2DA23-DF34-4560-9649-7B24E6281E4C

Q37445860-0A932A9A-465C-4C4A-82C9-DB97AA617CCB

Q37445860-0ACB1AE4-50AD-43CB-8770-344B37A92E85

Q37445860-0DC63257-7411-494F-A0A9-B8E328ABCAE9

Q37445860-1318AF0B-DF06-4C94-A69C-379185250168

P304

Q37445860-ED2A1E7A-2D1A-4AD0-954E-A1E01CD7B39A

P31

Q37445860-CBB6A513-1198-405E-BFD6-02930CF23CB8

P356

Q37445860-4E1D725A-0CBE-4B03-A296-308D20F52155

P433

Q37445860-CF961ADE-3702-423B-BBD6-96603D1F3A11

P478

Q37445860-6654A4D6-4C46-4FCE-91AA-A00E6265BF9D

P50

Q37445860-56EA819F-12FE-4EB3-95A6-046A9698B0F3

P577

Q37445860-582F9912-2902-46AF-BEB5-0129B36DE9A7

P5875

Q37445860-EC7AC53B-C51E-4BEA-92CA-570E5E265D36

P698

Q37445860-5EFE2EFC-A7F2-405B-920D-AA992929F5F9

P356

14796678.5.2.141

P1433

Future Cardiology

P1476

Drug-eluting stents: a comprehensive appraisal.

@en

P2093

Derek Connolly

http://www.w3.org/2001/XMLSchema#string

Mehmood Butt

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Very late thrombosis after implantation of sirolimus eluting stent

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

Physiological transport forces govern drug distribution for stent-based delivery

What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interven

P304

141-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796678.5.2.141

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Gregory Y. H. Lip

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24282169

http://www.w3.org/2001/XMLSchema#string

P698

19371189

http://www.w3.org/2001/XMLSchema#string